11 March 2024

By The Numbers - part the fifty first

Another day, another clinical trial failure: a schizo drug, been in 'development' since Hector was a pup. This compound with a p-value of .4825; not in the ballpark, but may be the same continent.

The takeaway from all this: CNS (central nervous system) drugs are no better than a crap shoot. Despite all the 'advances' in AI, we humans still don't know how our little grey cells actually work; and what it is that makes them stop working. If we did, we'd have figured all this stuff out a long time ago.

For once a sponsor does say, No mas!!
We will continue to analyze these data with our scientific advisors, but we do not intend to conduct any further clinical trials with pimavanserin.
-- Steve Davis - CEO

No comments: